Novartis to acquire AveXis for $8.7bn to expand gene therapy and neuroscience portfolio

Novartis to acquire AveXis for $8.7bn to expand gene therapy and neuroscience portfolio

Novartis, a Swiss pharmaceutical giant, has confirmed a substantial acquisition of AveXis, a US-based gene therapy company, for a total of $8.7 billion. This strategic move is set to enhance Novartis’s capabilities in gene therapy and neuroscience, particularly in the treatment of spinal muscular atrophy (SMA). Strategic Acquisition in Pharma Under the agreement, Novartis will […]

Unilever’s mayonnaise brand launches Hellmann’s REAL Ketchup in US

Unilever’s mayonnaise brand launches Hellmann’s REAL Ketchup in US

Food product launch : Unilever’s US mayonnaise brand Hellmann’s has rolled out its first ketchup product – Hellmann’s REAL Ketchup to retailers across the country. Hellmann’s says that its new ketchup product is made with six ingredients that include tomato puree, honey, spices, white wine vinegar, onion powder, and salt. Honey has been used in […]

Nestle completes $2.8bn sale of US confectionery business to Ferrero

Nestle completes $2.8bn sale of US confectionery business to Ferrero

Confectionery industry news : Nestle has completed its previously announced $2.8 billion sale of its US confectionery business to Italian chocolate manufacturer Ferrero. The Swiss food and beverage giant entered into the deal in January 2018 to sell its US confectionery business in a move to focus on its core products. Through the acquisition, Ferrero […]

Danish Crown subsidiary takes majority stake in Shanghai Natural Casing

Danish Crown subsidiary takes majority stake in Shanghai Natural Casing

Food acquisition news : DAT-Schaub, a subsidiary of global meat processing company Danish Crown is all set to expand its operations in China with the acquisition of a majority stake in Shanghai Natural Casing Company, a natural casings manufacturer, for an undisclosed price. Based in Denmark, DAT-Schaub provides natural and artificial casings and ingredients to […]

GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

In a major strategic shift, GlaxoSmithKline (GSK) has finalized an agreement to acquire Novartis’ 36.5% stake in their consumer healthcare joint venture for $13 billion. This move comes shortly after GSK withdrew from a $20 billion bid to purchase Pfizer’s consumer healthcare business, indicating a focused realignment of GSK’s investment towards owning 100% of its […]